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Interleukin-8 (IL-8) promotes neutrophil-mediated
host defense through its chemoattractant and immu-
nostimulatory activities. The Group A Streptococcus
(GAS) protease SpyCEP (also called ScpC) cleaves
IL-8, and SpyCEP expression is strongly upregulated
in vivo in the M1T1 GAS strains associated with life-
threatening systemic disease including necrotizing
fasciitis. Coupling allelic replacement with heterolo-
gous gene expression, we show that SpyCEP is nec-
essary and sufficient for IL-8 degradation. SpyCEP
decreased IL-8-dependent neutrophil endothelial
transmigration and bacterial killing, the latter by
reducing neutrophil extracellular trap formation.
The knockout mutant lacking SpyCEP was attenu-
ated for virulence in murine infection models, and
SpyCEP expression conferred protection to coin-
fecting bacteria. We also show that the zoonotic
pathogen Streptococcus iniae possesses a func-
tional homolog of SpyCEP (CepI) that cleaves IL-8,
promotes neutrophil resistance, and contributes to
virulence. By inactivating the multifunctional host
defense peptide IL-8, the SpyCEP protease impairs
neutrophil clearance mechanisms, contributing to
the pathogenesis of invasive streptococcal infection.
INTRODUCTION
Group A Streptococcus (GAS) is a leading human pathogen
responsible for a wide range of diseases ranging from simple
pharyngitis and impetigo to life-threatening, invasive conditions
such as necrotizing fasciitis (NF) and toxic shock syndrome
(TSS). The worldwide burden of invasive GAS infection is esti-
mated at over 650,000 cases and 150,000 deaths annually (Car-
apetis et al., 2005). While GAS strains of many genotypes are
capable of producing invasive infections, strains representing
one globally disseminated M1T1 clone have persisted for over
20 years as the most prevalent sterile site isolates (Chatellier170 Cell Host & Microbe 4, 170–178, August 14, 2008 ª2008 Elsevieet al., 2000; Cleary et al., 1998; Cockerill et al., 1997; Murono
et al., 1999), as corroborated by the nine surveillance centers
of the United States Centers for Disease Control Emerging
Infections Program Network each year from 1997 though 2005
(http://www.cdc.gov/ncidod/dbmd/abcs).
Sumby et al. recently provided a genome-wide analysis using
expression microarrays to characterize fundamental differences
in the transcriptome of M1T1 GAS isolates isolated from invasive
disease cases versus those associated with mucosal site infec-
tion (Sumby et al., 2006). This comprehensive analysis showed
that a frameshift mutation in the gene covS, encoding the sensor
kinase component of an important GAS global transcriptional
regulator (Dalton et al., 2006; Mitrophanov et al., 2006), resulted
in striking effects on GAS gene expression including the upregu-
lation of several proven or candidate virulence factors. A second
most highly upregulated gene (25-fold) in the invasive GAS tran-
scriptional profile was that encoding SpyCEP (S. pyogenes cell
envelope protease). SpyCEP (also known as ScpC and PrtS) is
a predicted 1645 amino acid protein that contains a C-terminal
LP(X)TG cell wall anchor, and it was recently identified as a
protease capable of degrading and functionally inactivating
the major human CXC chemokine interleukin-8 (IL-8) (Edwards
et al., 2005; Hidalgo-Grass et al., 2006).
IL-8 is a multifunctional host defense protein with a prominent
role in recruitment and activation of neutrophils. Not only does
IL-8 act as potent chemoattractant (Kunkel et al., 1991), it also
tethers itself to the luminal surface of the microvasculature pro-
viding a stop signal to rolling neutrophils (DiVietro et al., 2001;
Middleton et al., 1997). SpyCEP purified from an M81 GAS NF
isolate was found to specifically cleave the IL-8 C terminus be-
tween a glutamine residue at position 59 and an arginine residue
at position 60, eliminating its chemotactic properties (Edwards
et al., 2005); the murine chemokine MIP-2 was cleaved at the
same site. Independent studies in a GAS M14 NF isolate
(Hidalgo-Grass et al., 2006) revealed that the same protease
also efficiently degraded the murine CXC chemokines KC and
MIP-2 both in vitro and in vivo, impairing mouse neutrophil
recruitment to a greater extent than the related GAS protease
ScpA, which specifically targets the human complement-derived
chemoattractant C5a (Cleary et al., 1992; Ji et al., 1996).
Due to its marked upregulation in the invasive transcriptional
profile, we hypothesized that SpyCEP played an important roler Inc.
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SpyCEP and GAS Neutrophil EvasionFigure 1. SpyCEP Is Necessary and Sufficient for IL-8 Degradation and Impairment of Neutrophil Recruitment
(A and B) SpyCEP expression was manipulated by targeted mutagenesis of GAS (loss of function), complementation, and heterologous expression in L. lactis
(gain of function). Presence of SpyCEP correlates with IL-8 protease activity by anti-IL-8 western blot (A) and ELISA (B). Error bars represent mean ± standard
deviation.
(C) SpyCEP degradation of IL-8 impairs human neutrophil transmigration across an endothelial monolayer. Recombinant IL-8 was used as a positive control.
Transmigration indicates migration of neutrophils across the endothelium. Transwell experiments were performed in triplicate and repeated three times; pooled
data are shown ± SEM. ‘‘Vector’’ refers to empty plasmid pDCerm to serve as control for complementation analysis.in M1T1 GAS resistance to phagocytic clearance and animal
virulence. To test this hypothesis, we deleted the gene encoding
SpyCEP, cepA, in an invasive M1T1 NF isolate through precise,
in-frame allelic replacement. This loss of function reagent is
coupled with heterologous expression of SpyCEP in the non-
pathogenic Gram-positive Lactococcus lactis to probe potential
pathogenic roles of the chemokine protease in promoting GAS
resistance to human neutrophil killing, adherence and invasion
of epithelial cells, and virulence in murine models of NF and
upper respiratory tract infection.
RESULTS
Mutagenesis and Heterologous Expression of SpyCEP
A strategy for precise, in-frame allelic replacement of the cepA
gene with a chloramphenicol acetyltransferase (cat) antibiotic re-
sistance gene cassette was executed successfully in M1T1 GAS
strain 5448, an isolate from a patient with NF and TSS, yielding
mutant 5448DcepA (Figure S1A). The intact M1T1 cepA gene
was also cloned in the Escherichia coli-streptococcal shuttle ex-
pression vector pDCerm (Jeng et al., 2003), generating pcepA,
for use in complementation analysis and heterologous expres-
sion of the protease in Lactococcus lactis. Western blot analysis
detected the presence of SpyCEP in culture supernatants of the
WT M1TI GAS parent strain, loss of expression in the isogenicCell HoDcepA mutant, and overexpression of SpyCEP upon comple-
mentation of the mutant or expression in L. lactis using the
high-copy number pcepA plasmid (Figure S1B). SDS-PAGE
showed generation of the 6 kD SpyCEP IL-8 cleavage product
after coincubation of the supernatants from the WT GAS parent
strain, complemented DcepA mutant, and L. lactis expressing
pcepA with IL-8, but the cleavage product was absent in the
DcepA mutant or L. lactis containing the empty vector control
(Figure S1C). Western blot analysis (Figure 1A) and IL-8 ELISA
(Figure 1B) confirmed IL-8 protease activity of the corresponding
strains expressing SpyCEP and its absence in strains lacking the
protease. These studies confirm generation of loss-of-function
and gain-of-function bacterial reagents with alterations in IL-8
protease activity for analysis of functional interactions with
human neutrophils. TheDcepAmutant did not differ from the par-
ent strain in expression of M1 protein (Figure S2A), zone of b-he-
molysis surrounding colonies on blood agar plates (not shown),
DNase activity (Figure S2B), nor susceptibility to the cationic
antimicrobial peptide polymyxin B (MIC = 28 mg/ml for both).
SpyCEP Impairs Neutrophil Endothelial Transmigration
In response to the chemotactic signal of IL-8, neutrophils will
migrate directionally across a human microvascular endothelial
cell monolayer, a process we and others have modeled in vitro
using a transwell filter insert system (Doran et al., 2003; Edwardsst & Microbe 4, 170–178, August 14, 2008 ª2008 Elsevier Inc. 171
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cells (hBMEC) were propagated on transwells until tight junctions
were established, living bacteria placed in the bottom well along
with a fixed concentration of recombinant IL-8, and freshly iso-
lated human neutrophils added to the upper well. Neutrophil
transmigration of the endothelial monolayer toward the GAS
DcepA mutant and untransformed L. lactis was significantly
greater than observed with the WT GAS parent strain, comple-
mented DcepA mutant or L. lactis expressing pcepA (Figure 1C).
These studies confirm that GAS expression of the IL-8 protease
can retard directional migration of human neutrophils, and conse-
quently serve to delay the kinetics of the innate immune response.
SpyCEP Promotes Resistance to Neutrophil Killing
The very strong upregulation of cepA expression in the invasive
M1T1 GAS transcriptome suggested potential benefits to bacte-
rial survival beyond interference with neutrophil recruitment.
IL-8, formerly known as neutrophil activating peptide-1, is pro-
duced in large amounts by neutrophils themselves upon encoun-
tering bacteria (Bazzoni et al., 1991; Strieter et al., 1992), and in
an autocrine fashion can exert stimulatory effects on oxidative
burst function and release of granule enzymes amplifying bacte-
ricidal activity (Simms and D’Amico, 1997; Thelen et al., 1988).
We assessed the contribution of SpyCEP to bacterial survival
in a human neutrophil opsonophagocytic killing assay. WT
parent M1T1 GAS survived neutrophil killing 6-fold more than
DcepA mutant bacteria (p < 0.005); WT levels of neutrophil resis-
tance were restored by complementation of the mutant with the
pcepA expression vector (Figure 2A, left). Heterologous expres-
sion of SpyCEP in L. lactis increased survival of the transformed
bacterium in the neutrophil killing assay by 50% (p < 0.005)
(Figure 2A, right). Consistent with prior results (Hidalgo-Grass
et al., 2006), SpyCEP did not promote survival in human whole
blood (Figure S3A), suggesting its action to be predominantly
exerted at localized tissue sites of infection.
SpyCEP Reduces Neutrophil Production
of Extracellular Traps
Apart from their phagocytic function, neutrophils can efficiently
capture and kill microbes in the extracellular space by extrusion
of a matrix of DNA and histones known as neutrophil extracellular
traps, or NETs, which ensnare bacteria and subject them to mi-
crobicidal effectors including elastase and myeloperoxidase
(Brinkmann et al., 2004). M1T1 GAS express DNases including
the phage-encoded Sda1 that contribute to NET degradation
and immune evasion (Buchanan et al., 2006; Sumby et al.,
2005; Walker et al., 2007). NETs are induced by exposing human
neutrophils to IL-8 (Gupta et al., 2005). We thus hypothesized
that the IL-8 degradation by SpyCEP could reduce NET forma-
tion and thus bacterial killing, suggesting another mechanism
by which the IL-8 protease could impair host defense function.
Using a fluorescent assay for real-time visualization of NETs
(Buchanan et al., 2006), we confirmed the capacity of the
chemokine to stimulate NET formation by human neutrophils
(Figure 2B). We then visualized NET formation elicited by our iso-
genic bacterial strains in the presence of the inhibitor G-actin to
block DNase-mediated NET degradation. As shown in Figure 2B,
NETs were significantly more abundant in human neutrophils in-
cubated with theDcepAmutant than with the isogenic WT parent172 Cell Host & Microbe 4, 170–178, August 14, 2008 ª2008 Elseviestrain or the complemented mutant; conversely, NET production
was diminished in neutrophils exposed to L. lactis expressing
SpyCEP compared to L. lactis transformed with empty vector
control. A significant contribution of SpyCEP to M1 GAS survival
was maintained when phagocytosis was inhibited with cytocha-
lasin D, confirming a role in the pathogen’s resistance to extra-
cellular neutrophil killing mechanisms (Figure S3B). Furthermore,
a significant contribution of SpyCEP to GAS neutrophil survival
was also maintained when NET degradation was inhibited with
G-actin (Figure S3B). This indicates SpyCEP action affects
NET production rather than NET degradation, consistent with
the observation that WT and DcepA mutant GAS exhibit similar
DNase activity (Figure S2B). Also consistent with the hypothesis
that SpyCEP blocks NET production by ablating IL-8-induced
NET formation, addition of excess exogenous IL-8 to the assay
eliminated the differences in NET induction between WT and
DcepA mutant strains (Figure S3C).
SpyCEP Contributes to GAS Virulence in a Murine
Necrotic Skin Infection Models
A murine subcutaneous challenge model can be used to
examine the contribution of specific bacterial phentoypes to
the virulence of M1T1 GAS in vivo (Buchanan et al., 2006; Datta
et al., 2005; Sumby et al., 2005). Using inbred C57Bl6 mice, we
injected one shaved flank with 53 107 cfu of the WT M1T1 GAS
parent strain and the contralateral flank with an equivalent inoc-
ulum of the isogenic DcepA mutant. As shown in the graph and
representative photo of Figure 3A, the mean lesion size gener-
ated by the DcepA mutant was 50% that of the WT lesions
(p < 0.02). Histopathologic analysis showed increased neutrophil
recruitment in lesions generated by theDcepAmutant compared
to the WT parent strain (Figure 3B), confirming earlier indications
that SpyCEP can impair murine neutrophil recruitment in vivo
due to its shared activity against murine C-X-C chemokines KC
and MIP-2 (Hidalgo-Grass et al., 2006).
We next asked whether SpyCEP protection against neutrophil
killing was only afforded to individual bacterial cells themselves
expressing the surface-anchored IL-8 protease (action in cis),
or whether SpyCEP-mediated chemokine degradation could
protect other vulnerable bacteria in the local environment (action
in trans). To address this question, we performed a coinfection
experiments in which an equal concentration of WT M1 GAS
and isogenic DcepA mutant were inoculated in the same lesion
site. When lesions were biopsied and harvested 4 days later,
no survival advantage of the WT strain versus the mutant was
detected (Figure 3C), indicating the WT strain could rescue the
virulence defect of the mutant bacteria, presumably by decreas-
ing neutrophil recruitment, phagocytic ability, and NET formation
at the local site of infection. To extend this line of investigation,
we adopted a model of polymicrobial necrotizing infection, using
a vancomycin-resistant isolate of the nosocomial pathogen En-
terococcus faecalis (VRE), a frequent isolate from mixed etiology
wound and necrotizing soft tissue infections including Fournier’s
gangrene (Kuo et al., 2007; Ou et al., 1993). Necrotic skin lesions
produced by the WT M1 GAS + VRE were significantly larger than
those produced by the GAS DcepA mutant + VRE, and it was
shown that the presence of the WT strain (with SpyCEP expres-
sion) promoted survival of VRE (in vivo and in trans) in the mixed
infection model (Figure 3D).r Inc.
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SpyCEP and GAS Neutrophil EvasionFigure 2. SpyCEP Promotes GAS Resistance to Neutrophil Killing
(A) SpyCEP contributes to GAS survival and increases Lactococcus lactis survival upon coincubation with human neutrophils, experiments performed in triplicate
and repeated three times with similar results; representative experiment ± SEM.
(B) The presence of SpyCEP reduces IL-8-mediated induction of neutrophil extracellular traps (NETs) in response to bacterial exposure. Shown are fluorescent
images of NETs stained with Sytox Orange and overlaid upon brightfield image of neutrophils. Also shown are quantitative enumeration of NETs; experiments
performed in triplicate and repeated three times with similar results; representative experiment ± SEM, two-sided t test.SpyCEP Contributes to GAS Virulence following
Intranasal Infection
As GAS is also an important cause of upper and lower respiratory
tract infections, we next assessed the contribution of SpyCEP toCell Hvirulence following intranasal inoculation. We observed the WT
M1 strain to have a marked advantage in establishing upper
respiratory tract infection compared to the DcepA mutant
(Figure 3E). In contrast to subcutaneous infection, this challengeost & Microbe 4, 170–178, August 14, 2008 ª2008 Elsevier Inc. 173
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SpyCEP and GAS Neutrophil EvasionFigure 3. SpyCEP Contributes to GAS Virulence in a Murine Infection Models
(A) C57B16 mice were injected subcutaneously with equivalent inocula of the WT M1 GAS strain (left flank) and the isogenic DcepA mutant (right flank) and skin
lesion progression measured for 4 days; a representative photograph of skin lesions observed is shown.
(B) Representative histology (H&E stain) biopsies from skin lesions showing increased neutrophil recruitment at the DcepA mutant infection site (100x magnifi-
cation).
(C) In a competition experiment, WT M1 GAS and isogenic DcepA mutant were injected simultaneously s.c. injection and bacteria enumerated after 4 days; ratio
WT M1 GAS to isogenic DcepA mutant is shown.
(D) GAS SypCEP expression supports survival in vivo of vancomycin resistance Enterococcus faecalis (VRE) in a mixed infection model.
(E) SpyCEP contributes to GAS mucosal infection in an intranasal inoculation model.
(F) SpyCEP reduces GAS epithelial cell adherence and invasion. Elimination of SpyCEP increases the adherence and invasion of HEp-2 human pharyngeal
epithelial cells by M1 GAS. Experiments were performed in triplicate and repeated three times with similar results; representative experiment is shown ± standard
deviation.model involves interaction of GAS with epithelial cells. This raises
the possibility that in addition to immune resistance, changes in
epithelial cell binding of theDcepA mutant compared to WT GAS
could contribute to the observed in vivo attenuation, especially
since cepA shares 30% sequence identity and 50% se-174 Cell Host & Microbe 4, 170–178, August 14, 2008 ª2008 Elseviequence similarity with the GAS C5a peptidase, ScpA, which
may function as a GAS epithelial cell invasin (Purushothaman
et al., 2004). We therefore examined the contribution of SpyCEP
to GAS adherence to and invasion of cultured HEp-2 human pha-
ryngeal epithelial cells. The isogenic DcepA mutant was found tor Inc.
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(p < 0.01) than the GAS WT parent strain; complementation of the
mutant with the pcepA expression plasmid reversed the adher-
ence and invasion phenotype to nearly WT levels (Figure 3F).
These results show that in contrast to ScpA, SpyCEP does not
act as a GAS epithelial cell adhesin or invasin. An underlying
mechanism may be found in the recent observation that GAS
is capable of triggering IL-8 release from Hep-2 cells, and that
the cytokine can promote GAS entry into cells (Nobbs et al.,
2007); SpyCEP degradation of IL-8 would interfere with this
pathway. In sum, we conclude that chemokine and neutrophil
mediated host defense are operating in the nasal infection
model, and whatever contribtion SpyCEP contributes to reduce
GAS epithelial adherence is outweighed by its ability to blunt
immune clearance in vivo.
The Zoonotic Pathogen Streptococcus iniae Possesses
a Functional SpyCEP Homolog
The b-hemolytic species Streptococcus iniae is an important
pathogen in wild and aquacultured fish, where it can produce
a fatal meningoencephalitis (Agnew and Barnes, 2007). S. iniae
is also recognized as an emerging zoonotic pathogen of humans,
producing invasive cellulitis in fish handlers (Weinstein et al.,
1997). By whole genome pyrosequencing and bioinformatic
analysis, we identified an S. iniae gene encoding a 1631 amino
acid (aa) candidate protein sharing 54.4% aa identity and
66.2% aa similarity to SpyCEP of GAS, which we named CepI
(cell envelope proteinase of S. iniae) (Figure S4). The genomic
position of cepI is consistent with cepA in GAS—downstream
from a lactate oxidase gene, lctO (previously characterized in
S. iniae) (Gibello et al., 1999), and upstream of genes with high
similarity to spy_0421 and metG of M1 GAS (Ferretti et al.,
2001). Like GAS, S. iniae is virulent in the murine subcutaneous
infection model (Fuller et al., 2001). Targeted plasmid integra-
tional mutagenesis of the cepI gene in virulent S. iniae strain
K288 was performed (Figure S5A). Compared to the WT parent
strain, the S. iniae DcepI mutant lost the ability to degrade IL-8
(Figure S5B), showed increased sensitivity to human neutrophil
killing (Figure S5C), and generated smaller lesions in the murine
subcutaneous infection model (Figure S5D). Thus, a functional
homolog of SpyCEP is present in at least one additional bacterial
species, where it contributes as it does for GAS to chemokine
degradation, neutrophil resistance and disease pathogenesis.
DISCUSSION
The prominence of GAS among bacteria able to cause serious
systemic infections even in previously healthy humans reflects
the diverse capacities of this pathogen to avoid eradication by
phagocyte defenses of the innate immune system (Kwinn and
Nizet, 2007; Voyich et al., 2004). Resistance to neutrophil killing
involves the antiphagocytic properties of classical GAS virulence
factors such as the surface M protein and hyaluronic acid cap-
sule and cytolytic action of the pore-forming toxins streptolysin
S and streptolysin O. In the globally disseminated GAS M1T1
clone, accumulation of a larger repertoire of virulence factors
such as the streptococcal inhibitor of complement (SIC) protein
and the phage-encoded DNase Sda1 provide added capabilities
to resist effective opsonization and escape extracellular killing inCell HoNETs, finding corroboration in epidemiologic associations to
severe disease including NF.
In the present study, we establish molecular Koch’s postulates
for the contribution of IL-8 protease SpyCEP to impaired neutro-
phil recruitment and resistance to neutrophil killing, including
single gene complementation analysis and heterologous expres-
sion studies. M1T1 expression of SpyCEP had the anticipated
effect of delaying neutrophil endothelial transmigration and
recruitment to the tissues and promoting virulence (Edwards
et al., 2005; Hidalgo-Grass et al., 2006; Sumby et al., 2008).
These results find clinical correlation in the striking paucity of
neutrophils at the site of infection that was observed in a subset
of human cases of GAS NF consistent with a primary deficit in
chemoattractant function (Cockerill et al., 1998; Hidalgo-Grass
et al., 2004). Likewise, in a baboon model of GAS soft-tissue
infection, the risk of septicemia and mortality was inversely cor-
related to the magnitude of neutrophil influx at the site of infec-
tion (Taylor et al., 1999). However, in advanced human necrotic
disease, prominent neutrophil infiltrates ultimately accumulate
in association with proliferating bacteria (Dahl et al., 2002), as
could be expected since additional microbial components
(e.g., fMLP) and host inflammatory response proteins (e.g., C5a,
platelet activating factor) possess strong neutrophil chemoat-
tractant properties (Wagner and Roth, 2000).
Our data suggest the proteolytic inactivation of IL-8 by Spy-
CEP can exert additional effects to impair neutrophil killing of
M1T1 GAS even in late stage necrotic lesions. By eliminating
IL-8-induced NET production, SpyCEP can synergize with the
M1T1 DNase Sda1 (Buchanan et al., 2006; Sumby et al., 2005)
to impair NET-mediated extracellular bacterial killing. The cumu-
lative effect of these activities is consistent with our observation
that GAS expression of SpyCEP was necessary and sufficient to
promote bacterial survival in killing assays with isolated neutro-
phils, and for GAS to protect non-SpyCEP producing bacteria
from neutrophil killing in vivo (Figure 2). The specificity of our as-
says was aided by the achievement of single gene replacement
of cepA (independent of scpA) and single gene complementation
that were technically unsuccessful, respectively, in other recent
informative studies of the GAS IL-8 protease activity (Hidalgo-
Grass et al., 2006; Sumby et al., 2008). Nevertheless, it is likely
that bacterial and mouse strain specificities influence the
observed patterns of disease progression, since inflammatory
lesion size may also reflect a contribution from host neutrophils
that could be augmented in the absence of SpyCEP chemokine
degradation (Sumby et al., 2008).
The gene encoding SpyCEP was one of the most highly differ-
entially expressed upon comparison of the transcriptional profile
of invasive M1T1 GAS isolates versus similar clonal strains iso-
lated from the pharyngeal mucosa (Sumby et al., 2006). In simple
colonization, our results indicate SpyCEP may decrease epithe-
lial cell adherence and, therefore, its expression would not be
favored. The observed 25-fold upregulation of cepA expression
in the invasive transcriptional profile of M1T1 GAS strains is con-
sistent with our findings linking SpyCEP expression to resistance
to neutrophil killing, a selective pressure induced uniquely
in vivo. Our discovery and analysis of a functional SpyCEP ho-
molog in S. iniae may likewise explain the human disease poten-
tial of this zoonotic pathogen. Strategies directed at neutralizing
SpyCEP activity could prove useful as an adjunctive therapy tost & Microbe 4, 170–178, August 14, 2008 ª2008 Elsevier Inc. 175
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but rather to render it susceptible to our natural innate defenses.
EXPERIMENTAL PROCEDURES
Bacterial Strains
WT GAS M1T1 strain 5448 was originally isolated from a patient with NF and
TSS (Chatellier et al., 2000). S. iniae strain K288 was isolated from the brain
of a moribund hybrid striped bass at the Kent SeaTech aquaculture facility
(Buchanan et al., 2005). Also used were vancomycin-resistant Enterococcus
faecalis (VRE) (ATCC 51299) and nonpathogenic L. lactis strain NZ9000.
GAS, S. iniae, L. lactis, and VRE were grown in Todd-Hewitt broth (THB) (Difco,
BD Diagnostics) or TH agar plates, using 1 mg/ml chloramphenicol (Cm) or
2 mg/ml erythromycin (Em) selection where appropriate. E. coli TOP10 (Invitro-
gen) were grown in Luria-Bertani (LB) broth or LB agar plates using 100 mg/ml
ampicillin, 500 mg/ml Em, or 5 mg/ml Cm selection. GAS and L. lactis were
made competent for transformation by electroporation by growth in THB +
0.6% glycine. For use in neutrophils, whole blood, epithelial cell, and mouse
challenge studies, bacteria were grown to logarithmic phase in THB (OD600 =
0.4 = 2 3 108 cfu/ml), pelleted, washed, and resuspended in PBS or tissue
culture media at the desired concentration.
Allelic Exchange Mutagenesis of GAS
PCR was used to amplify upstream and downstream DNA fragments from the
M1 GAS 5448 chromosome immediately flanking the cepA gene. Primers pairs
used were (1) cepA-upF (50-ggtataagacggggtcaaca-30, 526 bp upstream of the
cepA start codon) with cepA-upR (50-ggtggtatatccagtgatttttttctccatctga
taccctcctaaatgtt-30; immediately upstream of the cepA start site + 30 bp
extension corresponding to 50 end of the cat gene) and (2) cepA-downF (50-
tactgcgatgagtggcagggcggggcgtaataacaaagcgcaaagagaca-30; immediately
downstream of the cepA stop codon + 30 bp extension corresponding to
the 30 end of the cat gene) with cepA-downR (50-gtcacatcagcagagctgtt-30;
526 bp downstream of the cepA stop codon). PCR was performed using the
two amplicons and an amplicon of the cat gene to yield a fusion product in
which cat replaced cepA precisely in GAS chromosomal context. This PCR
product was TA cloned into the Gateway entry vector, pCR8/GW/TOPO (Invi-
trogen), then subcloned into pKODestErm, a derivative of pHY304 constructed
to allow L-R combination of gene cassettes, thus generating knockout vector
pKO-cepA. This plasmid was transformed into GAS M1 and single recombina-
tion events identified at 37C under Em + Cm selection. Selection was relaxed
by serial passage at 30C without antibiotics and double-crossover events
identified by screening for colonies with CmR but EmS phenotype
(Figure S1A). Precise, inframe allelic exchange of cepA with cat in the GAS
5448DcepA mutant was confirmed by PCR analysis. M protein dot blot analy-
sis was performed on serial 10-fold dilutions of GAS cells using antibiodies
directed at the N-terminal domain of the M1 protein (Chatellier et al., 2000).
Polymyxin B MIC was determined on logarthmic phase bacteria after 24 hr in-
cubation with the peptide at 37C. DNase activity was tested by coincubating
the supernatants of logarithmic phase bacteria (OD 0.4) with calf thymus DNA
(1 mg/ml) and buffer (300 mM Tris, 3 mM CaCl2, 3mM MgCl2) for 15 min. The
reaction was stopped by adding 0.33 M EDTA and the extent of DNA degrada-
tion visualized by electrophoresis on a 1% agarose gel.
Complementation Studies and Heterologous Expression of cepA
The M1 GAS cepA gene and flanking was amplified by PCR from the GAS
chromosome using primers cepA-upF and cepA-downR, TA cloned into the
Gateway-TOPO vector, then subcloned using L-R recombinase into pDes-
tErm, a version of pDCerm (Jeng et al., 2003) engineered to contain L-R recom-
bination sequences in its multiple cloning site, generating expression vector
pcepA. This plasmid was electroporated into the GAS 5448DcepA mutant
and L. lactis strain NZ900 and transformants identified by EmR phenotype,
and confirmed by PCR and restriction analysis. Plasmid pDestErm was intro-
duced into the corresponding strains as an empty vector control.
Mutagenesis of S. iniae CepI
Whole genome pyrosequencing (454 Life Sciences) of the virulent S. iniae iso-
late K288 generated short sequence contigs with high BLAST similarity to the176 Cell Host & Microbe 4, 170–178, August 14, 2008 ª2008 ElsevieGAScepAgene (Hidalgo-Grass et al., 2006). Using preliminary public data from
the Baylor College of Medicine Human Genome Sequencing Center S. iniae
genomic sequencing project (http://www.hgsc.bcm.tmc.edu), we identified
the full putative S. iniae cepI gene and designed primers for mutagenesis.
The middle third of S. iniae cepI was amplified by PCR using primers cepI-
1632F (50-aggtcgtttacgatttgaaag-30) + cepI-3284R (50-tcttcaaccatataata-
gaag-30). The 1653 bp amplicon was cloned into pCR8GW/TOPO and then
subcloned via LR recombination into pKODestErm, as described for generation
of the GAS pKO-cepA knockout plasmid. Electrocompetent WT S. iniae K288
were transformed with the pKO-cepI plasmid. Positive EmR transformant colo-
nies growing at 30C were temperature shifted to 37C to select for bacteria
that underwent a single-crossover event in which the pKO-cepI was linearized
into the chromosome, disrupting the native cepI gene (Figure S5A). Insertion
mutants were confirmed through PCR analysis. For comparative analyses
with the EmR cepImutant, EmR was introduced into WT K288 through transfor-
mation with the empty pDestErm complementation vector (Locke et al., 2007).
For functional assays,S. iniaestrains were grown at 30C on THA agar or in THB
liquid media containing 5 mg/ml Em.
Western Blot and ELISA Analysis
For IL-8 detection, bacteria were grown to midlogarithmic phase, washed with
PBS, and resuspended in RPMI + 0,1% fetal calf serum (FCS). Human IL-8
(R&D Systems) was added to the bacterial suspensions at final concentration
of 1 mg/ml. After 4 hr (GAS) and 24 hr (S.iniae) incubation at 37C, the samples
were loaded and separated on a 4%–12% Tris-tricine in MES buffer (Invitro-
gen) and transferred to a nitrocellulose membrane. The membrane was
blocked with 5% nonfat milk + 0.2% Tween-20. Detection used primary anti-
body mouse anti-human-monoclonal IL-8 (R&D Systems), secondary antibody
peroxidase-conjugated sheep anti-mouse (GE Healthcare UK Limited), and
detected using the Supersignal West Pico Chemiluminiscent System (Pierce).
For detection of SpyCEP protein by GAS and L. lactis strains, rabbit polyclonal
antibody raised against a recombinant protein representing residues 35–587
of the pre-pro SpyCEP enzyme sequence at 1:1000 dilution was employed
and developed using Protein G-peroxidase (Sigma) and the ECL system.
To monitor IL-8 cleavage, 10 ml of cell-free supernatant from an overnight cul-
ture of each bacterial strain was coincubated with an equal volume of human
IL-8 (final concentration 5 mg/mL) at 37C. Samples were then electrophoresed
on a 12% Bis-Tris SDS PAGE gel (Invitrogen) in MES buffer and stained using
the colloidal blue staining kit (Invitrogen). Quantitative ELISA for IL-8 was
performed using the Quantikine kit (R&D Systems) as described previously
(Hidalgo-Grass et al., 2004).
Endothelial Transcytosis Assay
Transmigration of human neutrophils across polar human brain microvascular
endothelial cell (hBMEC) monolayers was assessed using an adaptation of
a published assay (Chen et al., 2006). Briefly, polar hBMEC monolayers
were established on collagen-coated TranswellTM plates (6.5 mm diameter,
3 mm pore size, Biocoat, BD Biosciences). Human neutrophils were purified
from healthy donors using the PolymorphPrepTM system (Axis-Shield, Fres-
nius) and 1 3 106 cells added to the upper well of the chamber. Midlog phase
GAS or L. lactis at 13 107 cfu/ml were pre-incubated with 70 ng/ml of recombi-
nant human IL-8 for 2 hr at 37C, then added to the lower well in 600 ml volume.
Recombinant human IL-8 (40 ng) was added to the lower well as a positive
control. Plates were incubated for 150 min at 37C in 5% CO2 before direct
enumeration of neutrophils transcytosing to the lower well in a counter cham-
ber (average of 4 high-power fields).
Neutrophil and Whole-Blood Killing Assays
Neutrophils were isolated from the blood of healthy volunteers as above. Log-
arithmic phase bacteria were preopsonized in 80% autologous human plasma
for 30 min at 37C, added to neutrophils at final multiplicity of infection (MOI) =
2.5 bacteria/neutrophil, then incubated for 30 min at 37C with orbital rotation.
In stated assays, G-actin 100 mg/ml, to inhibit DNase activity, or cytochalasin D
10 mg/ml, to inhibit phagocytosis, were added to the neutrophils during 10 min
preincubation before addition of bacteria. Neutrophils were then lysed with
sterile H2O and serial dilutions plated on THA for enumeration of surviving bac-
terial cfu. For visualization of NETs, bacteria were mixed with neutrophils at
MOI = 0.1 in the presence of G-actin 100 mg/ml for 5 min to inhibit GAS DNaser Inc.
Cell Host & Microbe
SpyCEP and GAS Neutrophil Evasionactivity (Buchanan et al., 2006), 0.1 mM Sytox orange stain (Molecular Probes,
Invitrogen) for extracellular DNA added, and the mixture immediately visual-
ized without fixation or washes using a Nikon TE200 inverted fluorescent
microscope with image capture by CCD camera. In stated assays exogenous
IL-8 was added at a final concentration of 2.5 mg/mL. For quantification NETs
were enumerated by counting three transects of three independent wells after
staining with Sytox orange. For whole-blood killing, phlebotomy was per-
formed on healthy volunteers, and 104 cfu of midlog phase GAS in 100 ml
were added to 300 ml whole blood. Aliquots were plated on THB agar after
15 and 30 min for enumeration of surviving GAS cfu.
Epithelial Cell Adherence and Invasion Assays
HEp-2 human pharyngeal epithelial cells were cultured in RPMI media + 10%
FCS, split into 24-well plates, and allowed to grow to confluence for 48 hr prior
to assays. Using MOI = 5 bacteria/cell, cellular adherence and antibiotic pro-
tection (invasion) assays were performed as described (Timmer et al., 2006).
All assays were performed in quintuplicate and repeated three times with sim-
ilar results. For live cell imaging, HEp-2 cells were incubated with bacteria as
described for the adherence assay; however, the bacteria were prestained
for 30 min using Fluorescein isothiocyanate Isomer I (Fluka, Sigma-Alderich).
At the end of the assay, wells were treated for 10 min with the fish antimicrobial
peptide moronecidin (Lauth et al., 2002) at final concentration 4 mM to kill all
extracellular bacteria and Sytox Orange added to final concentration 0.1 mM
for staining of dead cells. Cells were visualized using a Nikon TE200 inverted
microscope with appropriate fluorescent filters and images captured with
a CCD camera.
Mouse Infection Models
GAS and S.iniae virulence was tested using an established murine model of
necrotizing skin infection (Buchanan et al., 2006; Nizet et al., 2001). Briefly, log-
arithmic phase GAS or S. iniae were resuspended in PBS, mixed 1:1 with
sterile Cytodex beads (Sigma, St. Louis, MO). An inoculum of 5 3 107 cfu of
WT GAS or S. iniae was injected subcutaneously into one flank of 10- to 12-
week-old C57Bl6 mice (Charles River Laboratories, CA), and simultaneously
an equivalent inoculum of the isogenic DcepA (DcepI) mutant was injected
into the contralateral flank, allowing each mouse (N = 16, GAS; N = 6, S. iniae)
to serve as its own control. The size of developing necrotic lesions was mon-
itored daily for 4 days, at which time mice were euthanized and histopathology
performed on formalin-fixed biopsy samples. Differences in lesion size were
analyzed using the paired Student’s t test. For a co-infection competition
model, 53 107 cfu of a 50:50 mix of WT GAS and isogenic DcepA GAS mutant
was injected subcutaneously into the shaved flank of C57Bl6 mice (N = 14); on
day 4, the skin was collected in order to enumerate the surviving bacteria with
strain determination by antibiotic selection and PCR confirmation. For the
polymicrobial infection model, 2.53 107 cfu of WT GAS or the isogenic DcepA
GAS mutant were mixed with an equivalent number of VRE and injected sub-
cutaneously into the shaved flank of C57Bl6 mice (N = 5); on day 4 the skin was
collected in order to enumerate the surviving bacteria. For upper respiratory
tract mucosal infection, 10- to 12-week-old C57Bl6 mice (N = 10 per group)
were infected intranasally with 1 3 108 cfu of WT GAS or isogenic DcepA
GAS mutant, respectively. After 4 days, the mice were euthanized, nose
excised and homogenized, and the surviving intranasal bacteria enumerated.
Differences were analyzed using an unpaired Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include five figures and Supplemental References and can
be found online at http://www.cellhostandmicrobe.com/cgi/content/full/4/2/
170/DC1/.
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